SaneVax, Inc.

Safe, Affordable, Necessary & Effective Vaccines and Vaccination Practices

Vaccination Persuasion Online: A Qualitative Study of Two Provaccine and Two Vaccine-Skeptical Websites

By

Authors: Lenny Grant, MA,MAT; Bernice L Hausman, PhD; Margaret Cashion, BS; Nicholas Lucchesi, BS; Kelsey Patel, BS; Jonathan Roberts, BA ABSTRACT Background: Current concerns about vaccination resistance often cite the Internet as a source of vaccine controversy. Most academic studies of vaccine resistance online use quantitative methods to describe misinformation on vaccine-skeptical websites. Findings from these […]

[Continue reading...]

Cervical screening rates for women vaccinated against human papillomavirus

By Leave a Comment

Screening Rates Authors: Budd AC1, Brotherton JM2, Gertig DM2, Chau T3, Drennan KT2, Saville M2 Abstract OBJECTIVE: To compare cervical screening rates for women vaccinated with a quadrivalent human papillomavirus (HPV) vaccine with those for unvaccinated women, to address concerns that vaccinated women may not be participating in cervical screening. DESIGN, SETTING AND PARTICIPANTS: Cross-sectional […]

[Continue reading...]

Transmission of Vaccine-Derived Rotavirus (RotaTeq)

By Leave a Comment

Sibling Transmission of Vaccine-Derived Rotavirus (RotaTeq) Associated With Rotavirus Gastroenteritis Rotavirus (RotaTeq) Authors: Daniel C. Payne, PhD, MSPHa, Kathryn M. Edwards, MDb, Michael D. Bowen, PhDc, Erin Keckley, RNb, Jody Peters, MSb, Mathew D. Esona, PhDc, Elizabeth N. Teel, BSc, Diane Kent, RNb, Umesh D. Parashar, MBBS, MPHa, Jon R. Gentsch, PhDc Abstract Although rotavirus vaccines are known to be shed in stools, transmission of […]

[Continue reading...]

From Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention in Clinical Practice

By Leave a Comment

Cervical Cancer Prevention Sin Hang Lee, Jessica S. Vigliotti, Veronica S. Vigliotti and William Jones Abstract: The newly gained knowledge of the viral etiology in cervical carcinogenesis has prompted industrial interests in developing virology-based tools for cervical cancer prevention. Due to the long incubation period from viral infection to developing an invasive cancer, a process whose […]

[Continue reading...]

Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe

By 1 Comment

Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe HPV Genotypes: Nyasha Chin’ombe1*, Natasha L Sebata1, Vurayai Ruhanya1 and Hilda T Matarira2 Abstract Cervical cancer is one of the major causes of morbidity and mortality in women in Zimbabwe. This is mainly due to the high prevalence of high-risk human papillomavirus (HPV) genotypes in the population. So […]

[Continue reading...]

HPV Vaccines: Have They Provided a Benefit for You?

By 4 Comments

Gardasil Cervarix HPV Vaccine Survey

Benefit? [SaneVax: The FDA/CDC and government health officials around the globe are brushing off adverse events experienced after HPV vaccinations as ‘coincidence’ despite the fact that these ‘coincidences’ are occurring at more than twice the rate of other vaccines. In direct response to government’s lack of concern independent research scientist, Dr. Chandler Marrs has taken up […]

[Continue reading...]

Influenza: marketing vaccine by marketing disease

By Leave a Comment

influenza virus 3d

Influenza Influenza… by Peter Doshi, Postdoctoral Fellow: BMJ 2013;346:f3037 The CDC pledges “To base all public health decisions on the highest quality scientific data, openly and objectively derived.” But Peter Doshi argues that in the case of influenza vaccinations and their marketing, this is not so. Promotion of flu vaccines is one of the most visible and aggressive public […]

[Continue reading...]

Vaccines and Medications: Undue Pharmaceutical Manufacturers’ Influence

By 1 Comment

Undue industry influences that distort healthcare research, strategy, expenditure and practice: a review. Stamatakis E, Weiler R, Ioannidis JP. Source Department of Epidemiology and Public Health, University College London, London, UK; Prevention Research Collaboration, School of Public Health, University of Sydney, Sydney, NSW, Australia. Abstract BACKGROUND: Expenditure on industry products (mostly drugs and devices) has spiraled over […]

[Continue reading...]

HPV vaccines and cancer prevention, science versus activism

By Leave a Comment

Lucija Tomljenovic, Judy Wilyman, Eva Vanamee, Toni Bark and Christopher A Shaw Infectious Agents and Cancer 2013, 8:6 doi:10.1186/1750-9378-8-6 Published: 1 February 2013 Abstract (provisional) The rationale behind current worldwide human papilloma virus (HPV) vaccination programs starts from two basic premises, 1) that HPV vaccines will prevent cervical cancers and save lives and, 2) have no risk of serious side effects. Therefore, efforts […]

[Continue reading...]

Self-Organized Criticality Theory of Autoimmuity

By Leave a Comment

Ken Tsumiyama1, Yumi Miyazaki1, Shunichi Shiozawa1,2,3,4* 1 Department of Biophysics, Kobe University Graduate School of Health Science, Kobe, Japan, 2 Department of Medicine, Kobe University Graduate School of Medicine, Kobe, Japan, 3 The Center for Rheumatic Diseases, Kobe University Hospital, Kobe, Japan, 4 Global Center of Excellence (GCOE), Tokyo, Japan Abstract Background The cause of autoimmunity, which is unknown, is investigated from a different […]

[Continue reading...]

Too Fast or Not Too Fast: The FDA’s Approval of Merck’s HPV Vaccine Gardasil

By Leave a Comment

Tomljenovic L, Shaw CA. Early career postdoctoral fellow in the Neural Dynamics Research Group at the University of British Columbia. Professor in the Department of Ophthalmology and Visual Sciences at the University of British Columbia and holds cross appointments with the Program in Experimental Medicine and the Graduate Program in Neuroscience. Abstract There are not many […]

[Continue reading...]

Public Awareness and Cervical Cancer Screening

By Leave a Comment

By P. Davies Article first published online: 16 MAY 2012 DOI: 10.1111/j.1365-2303.2012.00984.x © 2012 Blackwell Publishing Ltd Population-based, organized screening programmes can reduce cervical cancer rates by 80%,1 although this will only be achieved with high coverage of the target population.2–4 The introduction of vaccines protecting against oncogenic human papillomavirus (HPV) types 16 and 18 has provided a […]

[Continue reading...]

Mass psychogenic illness after vaccination

By 1 Comment

    PubMed.gov Drug Saf. 2003;26(9):599-604. Clements CJ. Source Department of Vaccines and Immunisation, World Health Organization, Geneva, Switzerland. ClementsCJ@telstra.com Abstract When vaccines are administered to groups, the physical reactions of the recipients may be similar, causing a form of mass reaction, the mechanism for which is the same as that for mass reactions from […]

[Continue reading...]

Autoimmune encephalitis: a case series and comprehensive review of the literature

By Leave a Comment

Wingfield T, McHugh C, Vas A, Richardson A, Wilkins E, Bonington A, Varma A. Source The Monsall Unit, Department of Infectious Diseases and Tropical Medicine, North Manchester General Hospital, Manchester, UK. tomwingfield@hotmail.co.uk Abstract Encephalitic syndromes are a common medical emergency. The importance of early diagnosis and appropriate treatment is paramount. If initial investigations for infectious agents prove negative, other diagnoses must […]

[Continue reading...]

Assuring the Quality, Safety, and Efficacy of DNA Vaccines

By Leave a Comment

Robertson JS, Griffiths E Source National Institute for Biological Standards and Control, Herts, UK. Methods Mol Med. 2006;127:363-74. Abstract Scientists in academia whose research is aimed at the development of a novel vaccine or approach to vaccination may not always be fully aware of the regulatory process by which a candidate vaccine becomes a licensed product. It […]

[Continue reading...]

Investigating Viruses in Cells Used to Make Vaccines; and Evaluating the Potential Threat Posed by Transmission of Viruses to Humans

By Leave a Comment

FDA Vaccines Blood & Biologics Principal Investigator: Arifa S. Khan, PhD Office / Division / Lab: OVRR / DVP / LR General Overview The emergence of pathogenic virus infections like influenza and HIV have created an urgent need for new vaccines. Virus-based vaccines are made in living cells (cell substrates). Some manufacturers are investigating the […]

[Continue reading...]

Attitudes toward HPV Vaccination among Women Aged 27 to 45.

By Leave a Comment

Pub Med SRN Obstet Gynecol.2011;2011:670318. Epub 2011 Apr 7. Weiss TW, Rosenthal SL, Zimet GD. Source Global Health Outcomes, Merck & Co., Inc., P.O. Box 4, WP97-A243, 770 Sumneytown Pike, West Point, PA 19486-0004, USA. Abstract The purpose of this study was to identify attitudes toward HPV vaccination among US women 27 to 45 years […]

[Continue reading...]

Estrogens regulate neuroinflammatory genes via estrogen receptors alpha and beta in the frontal cortex of middle-aged female rats

By Leave a Comment

7th Space Interactive July 23, 2011 Estrogens exert anti-inflammatory and neuroprotective effects in the brain mainly via estrogen receptors alpha (ERalpha) and beta (ERbeta). These receptors are members of the nuclear receptor superfamily of ligand-dependent transcription factors. This study was aimed at the elucidation of the effects of ERalpha and ERbeta agonists on the expression […]

[Continue reading...]

Infant mortality rates regressed against number of vaccine doses routinely given: Is there a biochemical or synergistic toxicity?

By

Neil Z Miller and Gary S Goldman Abstract The infant mortality rate (IMR) is one of the most important indicators of the socio-economic well-being and public health conditions of a country. The US childhood immunization schedule specifies 26 vaccine doses for infants aged less than 1 year—the most in the world—yet 33 nations have lower […]

[Continue reading...]

Equality of the sexes? Not always when it comes to biology

By Leave a Comment

‘Man flu’ is real According to Cambridge University researchers, evolutionary factors have led to the male system becoming more vulnerable to illness. Kipnews.org Posted: 28th June 2011 by MaxWild in Health & Nutrition MUHC researchers demonstrate that estrogen renders the innate immune system of women more powerful than that of Men Montreal, May 11, 2009 […]

[Continue reading...]

News

Videos

Contact